CA ATC L01CB01 · updated 2 Nov 2026
Etoposide shortage in Canada
Is there an Etoposide shortage in Canada?
Yes. As of 2 Nov 2026, 2 Etoposide products are reported short in Canada, the first since 4 Sep 2026. The company estimate for the return is 28 Feb 2027. Main reason: manufacturing problem.
Also short in Italy, Belgium, Switzerland, Czechia, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | VEPESID (bottle of 20 caps) | CHEPLAPHARM ARZNEIMITTEL GMBH | 4 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ETOPOSIDE INJECTION (10ml 25ml) anticipated | TEVA CANADA LIMITED | 31 Dec 2026 | 28 Feb 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.